Profile picture

Mr Thomas Michaeli

Mannheim (Germany)
Follow
Biography
Medical doctor at the University Medical Centre Mannheim at Heidelberg University and clinican scientist at the DKFZ-Hector Institute for Personalized Oncology at the German Cancer Research Center (DKFZ). Research interests include cardiology, oncology, and health policy.
Logo ESC

Contributor content

Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK
Presentation
Cost-effectiveness of icosapent ethyl for primary and secondary cardiovascular prevention in the UK
Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab
Presentation
Cost-effectiveness of cholesterol-lowering drugs for secondary cardiovascular prevention in the UK: ezetimibe, evolocumab, and alirocumab

ESC 365 is supported by